Celltrion
068270.KS
#657
Rank
A$46.77 B
Marketcap
$225.83
Share price
0.00%
Change (1 day)
32.54%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of June 2024 : A$18.46 B

According to Celltrion 's latest financial reports the company has A$18.46 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$A$4.98 B6.4%
2021-12-31$A$4.68 B14.34%
2020-12-31$A$4.09 B15.85%
2019-12-31$A$3.53 B7.13%
2018-12-31$A$3.29 B13.91%
2017-12-31$A$2.89 B22.11%
2016-12-31$A$2.37 B19.26%
2015-12-31$A$1.98 B32.53%
2014-12-31$A$1.50 B29.8%
2013-12-31$A$1.15 B18.49%
2012-12-31$A$0.97 B28.94%
2011-12-31$A$0.75 B10.72%
2010-12-31$A$0.68 B146.3%
2009-12-31$A$0.27 B8.35%
2008-12-31$A$0.25 B679.63%
2007-12-31$A$32.84 M